Startups channel feed – Endpoints News

Startups channel feed

Former Voyager CEO Andre Turenne makes a comeback with Atlas-backed covalent drug biotech

3 years ago

A French biotech nabs Series A to see if it can carve a role in the ADC space

3 years ago

‘Pluck those diamonds’: Bayer’s Vividion eyes up to nine oncology targets from Duke spinout

3 years ago

Michael Ehlers and Romesh Subramanian launch biotech with $50M, sea squirt-inspired RNA-editing tech

3 years ago

Armed with $125M, Nested Therapeutics debuts with plan to jumpstart next-gen precision oncology efforts

3 years ago

California dreamin': Red Tree VC shop takes Boston funds' spinout approach to West Coast

3 years ago

A dozen years in the making, a UC Berkeley spinout nabs funds to take on the eye

3 years ago

Bristol Myers inks protein degrader deal via Celgene team's link to seed-stage biotech

3 years ago

A year and a half after Cellarity raised $123M, the Flagship biotech is back — and it's ready to pick out candidates

3 years ago

Wyss Institute spinout looks to revamp drug development for CNS diseases — with CRISPR tadpoles

3 years ago

'Structure, beauty and clarity': With seed financing, Kaleidoscope aims to synchronize R&D teams

3 years ago

Bristol Myers got the first TYK2 approval. Frazier’s new biotech Sudo hopes to get many more

3 years ago

A new ADC biotech looks to revive secretive platform, secures Big VC backing

3 years ago

George Church’s woolly mammoth revival biotech Colossal spins out computational bio outfit

3 years ago

TCR upstart gets fresh funding as it looks to charge toward the clinic

3 years ago

MD Anderson wants to 'be part of the game,' partners with Radiopharm Theranostics for radioligand joint venture

3 years ago

From three companies to one — Galvanize Therapeutics gets $100M to push electric field therapy

3 years ago

Backed by five pharma giants and a crew of Penn superstars, a startup uses mRNA to create in vivo CAR-T — with a pro at the helm

3 years ago

‘Difficult to go public with’: SparingVision turns to existing backers to fund its first two ocular gene therapy trials

3 years ago

The scientist who pioneered KRAS drugs has a new idea about making them more powerful

3 years ago

Freshly baked: Pretzel Therapeutics takes out the oven mitts to drug diseases in the powerhouse of the cell

3 years ago

Deerfield backs a Penn spinout aiming to shake up Parkinson's treatments using stem cells, brain surgery

3 years ago

Going beyond protein degradation, a new Broad startup kicks into gear to fix protein functionality

3 years ago

Innovation Endeavors doles out first investment in the Joel Dudley era, with seed funding for a small molecule startup

3 years ago

First page Previous page 37 38 394041 42 43 Next page Last page